Vimarsana
Biggest News Aggregation in the World

Page 9 - Minimum Bid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Minimum Bid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Minimum Bid Today - Breaking & Trending Today

Safe T : Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements No Immediate Effect on Nasdaq Listing or Trading of the Company's ADSs - Form 6-K - Vimarsana News

Safe T : Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements No Immediate Effect on Nasdaq Listing or Trading of the Company's ADSs - Form 6-K

Safe-T Group Ltd. Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirements No Immediate Effect on Nasdaq Listing or Trading of the Company's ADSs ... | July 13, 2022

Engine Gaming & Media Holdings, Inc.: Engine Gaming & Media Confirms Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Vimarsana News

Engine Gaming & Media Holdings, Inc.: Engine Gaming & Media Confirms Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

NEW YORK, NY / ACCESSWIRE / June 28, 2022 / Engine Gaming and Media, Inc. ("Engine" or the "Company") (NASDAQ:GAME)(TSXV:GAME), a data-driven, gaming, media and social influencer marketing solutions company

SIGILON THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Vimarsana News

SIGILON THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On June 22, 2022, Sigilon Therapeutics, Inc. received written notice from the Listing... | June 23, 2022

Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq - Vimarsana News

Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq

SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company...

Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Vimarsana News

Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

17.06.2022 - SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) - Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, ...